Get more replies from employers
Send a job-specific resume in minutes.
insitro is a physical AI company enabling causal biology through the Virtual Human platform. The Staff Software Engineer on the Imaging Software team will shape the ML infrastructure for high-content imaging, from microscope data to scalable pipelines, partnering with scientists to turn prototypes into validated workflows, and setting the technical direction for automation in drug discovery.
The role is based in South San Francisco with an in-person hybrid schedule (3 days/week) and reports to
insitro is a physical AI company dedicated to unlocking causal human biology and accelerating the delivery of better medicines to patients. Our unique Virtual Human™ platform identifies novel, high-impact genetic intervention points, which our TherML™ platform translates into therapeutics—whether small molecules, biologics, or oligos. With multiple programs in metabolic disease and neuroscience advancing toward the clinic, and our first IND submission slated for the second half of this year, we are at a pivotal inflection point.
As a Staff Software Engineer on our Imaging Software team, you will define and expand our computer vision and ML infrastructure across the full imaging data lifecycle - from on-microscope acquisition to high-throughput ML pipelines. You'll build the platform features that make novel imaging modalities and ML-derived phenotypes integral to our discovery workflows, partnering daily with lab scientists, ML scientists, and our microscopy team to turn research prototypes into validated screening workflows that run reliably at laboratory automation scale. This is a chance to set the technical direction for how imaging, automation, and machine learning converge in drug discovery.
Based in South San Francisco, this position reports directly to the Director of Imaging, Cellular Machine Learning and offers an in-person hybrid schedule of three days per week.
Platform & Tooling
Production Hardening & Data Integrity
Cross-Functional Partnership
Experience & Qualifications
Core Competencies
Our target starting salary for successful US-based applicants for this role is $219,000 - $233,000. To determine starting pay, we consider multiple job-related factors including a candidate's skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams-grounded in a wide range of expertise and life experiences and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.
#LI-Hybrid
About insitro
insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.